Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glomerulonephritis, IGA”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Looking for participantsNCT04662723
What this trial is testing

Multicentre Clinical Study to Evaluate the Effect of Personalized Therapy on Patients With Immunoglobulin A Nephropathy.

Who this might be right for
GlomerulonephritisImmunoglobulin A Nephropathy
Fondazione Schena 878
Not applicableLooking for participantsNCT02954419
What this trial is testing

IgA Nephropathy Biomarkers Evaluation Study (INTEREST)

Who this might be right for
IgA NephropathyGlomerular Diseases
Sun Yat-sen University 2,000
Not applicableStudy completedNCT01835639
What this trial is testing

Vitamin D Supplementation in Glomerular Disease

Who this might be right for
Glomerular Disease
Children's Hospital of Philadelphia 32
Very early researchNot Yet RecruitingNCT07535138
What this trial is testing

Efficacy and Safety of CD19 CAR-γδ T Cells in the Treatment of Relapsed/Refractory Autoimmune Nephropathy

Who this might be right for
Membranous NephropathyLupus Nephritis (LN)IgA Nephropathy (IgAN)
Air Force Military Medical University, China 15
Post-approval studies (Phase 4)UnknownNCT02981212
What this trial is testing

Efficacy and Safety of a Combination of Mycophenolate Mofetil and Corticosteroid in Advanced IgA Nephropathy

Who this might be right for
IgA Nephropathy
Yonsei University 100
Not applicableLooking for participantsNCT07822100
What this trial is testing

To Assess the Efficacy and Safety of Utilizing Galactose-deficient IgA1 Biomarker Changes to Guide Pathogenic IgA-targeted Therapeutic Strategies

Who this might be right for
IgA Nephropathy (IgAN)Henoch Schönlein Purpura Nephritis
Hong Zhang 374
Large-scale testing (Phase 3)Study completedNCT03643965
What this trial is testing

Efficacy and Safety of Nefecon in Patients With Primary IgA (Immunoglobulin A) Nephropathy

Who this might be right for
Primary IgA Nephropathy
Calliditas Therapeutics AB 365
Not applicableStudy completedNCT05434325
What this trial is testing

TESTING -ON Post-Trial ObservatioNal Cohort Study

Who this might be right for
IgA NephropathyESRDGlomerulonephritis+1 more
The George Institute 211
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07773727
What this trial is testing

Evaluate the Effect of ARGX-121 on the Change in Proteinuria in Adult Participants With IgAN

Who this might be right for
Immunoglobulin A Nephropathy (IgAN)
argenx 120
Large-scale testing (Phase 3)Looking for participantsNCT07024563
What this trial is testing

Study of Ravulizumab in Pediatric Participants With Primary IgAN

Who this might be right for
IgANIgAVNImmunoglobulin A Nephropathy+3 more
Alexion Pharmaceuticals, Inc. 36
Not applicableLooking for participantsNCT06065852
What this trial is testing

National Registry of Rare Kidney Diseases

Who this might be right for
Adenine Phosphoribosyltransferase DeficiencyAH AmyloidosisAHL Amyloidosis+81 more
UK Kidney Association 35,000
Post-approval studies (Phase 4)UnknownNCT02765594
What this trial is testing

Hydroxychloroquine Sulfate Alleviates Persistent Proteinuria in IgA Nephropathy

Who this might be right for
Primary IgA Nephropathy
Peking Union Medical College Hospital 98
Post-approval studies (Phase 4)Study completedNCT00319761
What this trial is testing

Calcitriol in the Treatment of Immunoglobulin A (IgA) Nephropathy

Who this might be right for
IGA Nephropathy
Chinese University of Hong Kong 10
Large-scale testing (Phase 3)UnknownNCT02662283
What this trial is testing

Validity and Security of Reh-acteoside Therapy for Patients of IgA Nephropathy

Who this might be right for
IGA Nephropathy
Sun Yat-sen University 75
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06454110
What this trial is testing

Study of NM8074 in Patients With Immunoglobulin A Nephropathy (IgAN)

Who this might be right for
IgA Nephropathy
NovelMed Therapeutics 10
Testing effectiveness (Phase 2)Study completedNCT03453619
What this trial is testing

Phase II Study Assessing Safety and Efficacy of APL-2 in Glomerulopathies

Who this might be right for
IgA NephropathyLupus NephritisMembranous Nephropathy+2 more
Apellis Pharmaceuticals, Inc. 21
Large-scale testing (Phase 3)Active Not RecruitingNCT04557462
What this trial is testing

A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy

Who this might be right for
Primary IgA Nephropathy
Novartis Pharmaceuticals 448
Post-approval studies (Phase 4)Study completedNCT00367562
What this trial is testing

Inhibition of the Renin Angiotensin System Plus Corticosteroids for the Treatment of Proteinuria in IGA Nephropathy

Who this might be right for
IGA Nephropathy
Hospital Britanico 20
Large-scale testing (Phase 3)WithdrawnNCT02052219
What this trial is testing

BRILLIANT-SC: A Study of the Efficacy and Safety of Blisibimod Administration in Subjects With IgA Nephropathy

Who this might be right for
IgA Nephropathy
Anthera Pharmaceuticals
Testing effectiveness (Phase 2)Study completedNCT04291781
What this trial is testing

RC18 Administered Subcutaneously to Subjects With Primary IgA(Immunoglobulin A) Nephropathy

Who this might be right for
Primary IgA Nephropathy
RemeGen Co., Ltd. 44
Next Page